News | February 06, 2021
Pfizer registers Q3FY21 PAT at Rs. 141.24 Cr
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
The partnership is a significant step in delivering advanced cancer therapies to patients.
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
Subscribe To Our Newsletter & Stay Updated
